No Data
No Data
No Data
No Data
No Data
Buy Rating Affirmed: Strategic Partnerships and Clinical Milestones Propel Wave Life Sciences' Growth Potential
TipRanksApr 26 02:16 ET
Wave Life Sciences: A Promising Buy Rating Based on Strategic GSK Collaboration and Innovative SiRNA Platform
TipRanksApr 26 02:11 ET
Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug
Seeking AlphaApr 23 10:29 ET
As Part Of Wave Life Sciences' Ongoing Collaboration With GSK, GSK Has Selected Its First Two Oligonucleotide Programs, GSK Will Provide An Initiation Payment Of $12M
GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave's next generation GalNA
BenzingaApr 23 10:22 ET
Express News | Wave Life Sciences Ltd: Wave Is on Track to Initiate a Clinical Trial of Its Wholly Owned Inhbe Program for Obesity in 1Q 2025
Moomoo 24/7Apr 23 08:31 ET
Express News | Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in Sirna and Rna Editing
Moomoo 24/7Apr 23 08:30 ET
No Data
No Data